Abstract:Background: The existence of stem/progenitor cells in the endometrium was postulated many years ago, but the first functional evidence was only published in 2004. The identification of rare epithelial and stromal populations of clonogenic cells in human endometrium has opened an active area of research on endometrial stem/progenitor cells in the subsequent 10 years. Methods: The published literature was searched using the PubMed database with the search terms 'endometrial stem cells and menstrual blood stem cells' until December 2014. Results: Endometrial epithelial stem/progenitor cells have been identified as clonogenic cells in human and as label-retaining or CD44(+) cells in mouse endometrium, but their characterization has been modest. In contrast, endometrial mesenchymal stem/stromal cells (MSCs) have been well characterized and show similar properties to bone marrow MSCs. Specific markers for their enrichment have been identified, CD146(+)PDGFRβ(+) (platelet-derived growth factor receptor beta) and SUSD2(+) (sushi domain containing-2), which detected their perivascular location and likely pericyte identity in endometrial basalis and functionalis vessels. Transcriptomics and secretomics of SUSD2(+) cells confirm their perivascular phenotype. Stromal fibroblasts cultured from endometrial tissue or menstrual blood also have some MSC characteristics and demonstrate broad multilineage differentiation potential for mesodermal, endodermal and ectodermal lineages, indicating their plasticity. Side population (SP) cells are a mixed population, although predominantly vascular cells, which exhibit adult stem cell properties, including tissue reconstitution. There is some evidence that bone marrow cells contribute a small population of endometrial epithelial and stromal cells. The discovery of specific markers for endometrial stem/progenitor cells has enabled the examination of their role in endometrial proliferative disorders, including endometriosis, adenomyosis and Asherman's syndrome. Endometrial MSCs (eMSCs) and menstrual blood stromal fibroblasts are an attractive source of MSCs for regenerative medicine because of their relative ease of acquisition with minimal morbidity. Their homologous and non-homologous use as autologous and allogeneic cells for therapeutic purposes is currently being assessed in preclinical animal models of pelvic organ prolapse and phase I/II clinical trials for cardiac failure. eMSCs and stromal fibroblasts also exhibit non-stem cell-associated immunomodulatory and anti-inflammatory properties, further emphasizing their desirable properties for cell-based therapies. Conclusions: Much has been learnt about endometrial stem/progenitor cells in the 10 years since their discovery, although several unresolved issues remain. These include rationalizing the terminology and diagnostic characteristics used for distinguishing perivascular stem/progenitor cells from stromal fibroblasts, which also have considerable differentiation potential. The hierarchical relationship between clonogenic epithelial progenitor cells, endometrial and decidual SP cells, CD146(+)PDGFR-β(+) and SUSD2(+) cells and menstrual blood stromal fibroblasts still needs to be resolved. Developing more genetic animal models for investigating the role of endometrial stem/progenitor cells in endometrial disorders is required, as well as elucidating which bone marrow cells contribute to endometrial tissue. Deep sequencing and epigenetic profiling of enriched populations of endometrial stem/progenitor cells and their differentiated progeny at the population and single-cell level will shed new light on the regulation and function of endometrial stem/progenitor cells.

Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells

The Elusive Endometrial Epithelial Stem/Progenitor Cells

A Mechanisms of Endometrial Fibrosis and the Potential Application of Stem Cell Therapy

Drosophila Follicle Stem Cells Are Regulated by Proliferation and Niche Adhesion As Well As Mitochondria and Ros

Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosis

Endometrial stem/progenitor cells: the first 10 years

Advancements in Endometrial Epithelial Stem Cell Research

A perivascular niche supports endometrial epithelial regeneration

Current advances in understanding endometrial epithelial cell biology and therapeutic applications for intrauterine adhesion

Unraveling the Dynamics of Estrogen and Progesterone Signaling in the Endometrium: An Overview

Endometrial Perivascular Progenitor Cells and Uterus Regeneration

Stem Cells and Endometrial Regeneration: from Basic Research to Clinical Trial.

SMAD2/3 signaling in the uterine epithelium controls endometrial cell homeostasis and regeneration

The Endometrial Stem/Progenitor Cells and Their Niches

Involvement of Cyclin B1 in Progesterone-Mediated Cell Growth Inhibition, G2/M Cell Cycle Arrest, and Apoptosis in Human Endometrial Cell

Long-term maintenance of human endometrial epithelial organoids and their stem cell properties

Identification of cells with colony-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis

Development of A 3D Tissue Slice Culture Model for the Study of Human Endometrial Repair and Regeneration

Advanced Biomaterials for Promoting Endometrial Regeneration

Adult stem cells in endometrial regeneration: Molecular insights and clinical applications